USP Comment Letter: Submitted to FDA on Elemental Impurities in Drug Products Guidance for Industry (2016)

Submitted on August 29, 2016 - USP Comment Letter to FDA on draft guidance, “Elemental Impurities in Drug Products Guidance for Industry".

Docket Number FDA-2016-D-1692; Comments of USP on Elemental Impurities in Drug Products Guidance for Industry (Draft Guidance).